Altmetric: 99Citations: 134More detail Review Cancer nanomedicine: progress, challenges and opportunities
Postdoctorate, Centro de Nanosciencias y Nanotecnologia, Universidad Nacional Autónoma de México (UNAM)
Tamoxifen is the standard endocrine therapy for breast cancers, which require metabolic activation by cytochrome P450 enzymes (CYP). However, tumors have low CYP concentration, and thus, maximum pr...